Return to search

Tempus attracts $100m

Chicago-based Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, has raised $100 million in financing.

Chicago-based Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, has raised $100 million in financing. The backers included Baillie Gifford, Franklin Templeton, NEA, Novo Holdings and funds and accounts managed by T. Rowe Price.

Source: Press Release